Three independent discounted-cash-flow-style models value Soleno Therapeutics, Inc. Common Stock every trading day. 0 of 3 currently price SLNO above its market price.
| Free Cash Flow model | $-5.31 |
| Excess Profit model | $3.48 |
| Residual Earnings model | $6.99 |
| Dividend Discount model | — |
| Piotroski F-Score | 5 / 7 |
| Return on invested capital | +4.2% |
| Net debt / EBITDA | 5.6× |
| Gross margin | +98.6% |
| Revenue CAGR | — |
| Cash conversion | 2.2× |
| Dividend yield | — |
| Buyback yield | -26.5% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open SLNO in StockKitty